Avenanthramide A triggers potent ROS-mediated anti-tumor effects in colorectal cancer by directly targeting DDX3

Colorectal cancer (CRC) is a common malignant gastrointestinal tumor with high mortality worldwide. Drug resistance and cytotoxicity to normal cells are the main causes of chemotherapeutic treatment failure in CRC. Therefore, extracting the bioactive compounds from natural products with anti-carcino...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Rong, Yang, Peng, Li, Zongwei, Liu, Wen, Amin, Sajid, Li, Zhuoyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685981/
https://www.ncbi.nlm.nih.gov/pubmed/31391454
http://dx.doi.org/10.1038/s41419-019-1825-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685981/
https://www.ncbi.nlm.nih.gov/pubmed/31391454
http://dx.doi.org/10.1038/s41419-019-1825-5

Ejemplares similares